Business Segments

9 Months Ended

Oct. 02, 2021

Segment Reporting [Abstract]

Business Segments

12. Business Segments

The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by product group is as follows:

	Three Months Ended				Nine Months Ended
(in thousands)	October 2, 2021		September 26, 2020		October 2, 2021		September 26, 2020
Cyclo G6	$	3,145	$	2,776	$	10,093	$	7,812
Retina		7,777		4,429		22,012		11,171
Other(1)		2,342		1,598		6,544		5,060
Total revenues	$	13,264	$	8,803	$	38,649	$	24,043
(1) Includes service contract revenues of $387 and $302 and $1,061 and $929 recognized during the three and nine months ended October 2, 2021 and September 26, 2020, respectively. Includes $228 and $339 recognized revenue related to the exclusive distribution rights during the three and nine months ended October 2, 2021, respectively. Other also includes revenues from paid service, royalty, freight and legacy G probes.

Revenue information shown by geographic region, based on the sales destination, is as follows:

	Three Months Ended				Nine Months Ended
(in thousands)	October 2, 2021		September 26, 2020		October 2, 2021		September 26, 2020
United States	$	6,901	$	5,269	$	18,973	$	12,881
Europe		3,025		1,913		8,685		5,316
Asia/Pacific Rim		2,825		1,022		9,279		4,625
Rest of Americas		513		599		1,712		1,221
Total revenues	$	13,264	$	8,803	$	38,649	$	24,043

Revenues are attributed to countries based on the location of end customers.

Other than the United States, the Netherlands accounted for at least 10% of the Company’s revenues during the three months ended October 2, 2021, representing 10%. Other than the United States, Japan accounted for more than 10% of the Company’s revenues during the nine months ended October 2, 2021, representing 13%. Other than the United States, no individual country accounted for more than 10% of the Company’s revenues during the three and nine months ended September 26, 2020. The United States accounted for 52.0% and 59.9% of revenues for the three months ended October 2, 2021 and September 26, 2020, respectively, and for 49.1% and 53.6% of revenues for the nine months ended October 2, 2021 and September 26, 2020, respectively.